Lista de obras -

A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response

artículo científico publicado en 2008

A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).

artículo científico publicado en 2013

APNG as a prognostic marker in patients with glioblastoma.

artículo científico publicado en 2017

Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival

scientific article published in Scientific Reports

Clinical value of CD133 and nestin in patients with glioma: a population-based study

artículo científico publicado en 2014

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan

artículo científico publicado en 2016

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.

artículo científico publicado en 2018

Expression and prognostic value of JAM-A in gliomas.

artículo científico publicado en 2017

Expression and prognostic value of the WEE1 kinase in gliomas.

artículo científico publicado en 2016

Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype

artículo científico publicado en 2016

High levels of c-Met is associated with poor prognosis in glioblastoma

artículo científico publicado en 2015

MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.

artículo científico publicado en 2012

Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls

artículo científico publicado en 2014

P01.083 Expression and prognostic value of the immune checkpoint molecule galectin-9 in glioblastomas

P01.114 Expression and prognostic value of the immune checkpoint molecule galectin-9 in glioblastomas

P04.09THE PROGNOSTIC POTENTIAL OF CD133 AND NESTIN IN A POPULATION-BASED COHORT OF GLIOMA PATIENTS.

artículo científico publicado en 2014

P04.16THE BIOMARKER POTENTIAL OF MGMT PROTEIN EXPRESSION IN GLIOBLASTOMA IS IMPROVED BY EXCLUSION OF NON-TUMOR CELLS.

artículo científico publicado en 2014

P04.25 Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas

P04.41 Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas

PATH-52. TIME-VARYING EFFECT OF MGMT METHYLATION LEVEL ON SURVIVAL OF GLIOBLASTOMA MULTIFORME

Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival

artículo científico publicado en 2019

Prognostic value of Musashi-1 in gliomas.

artículo científico publicado en 2013

Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.

artículo científico

Quality of life in patients with cancer during the COVID-19 pandemic - a Danish cross-sectional study (COPICADS)

artículo científico publicado en 2020

STEM-13EXPRESSION OF STEM CELL, PROLIFERATION AND CHEMORESISTANCE MARKERS IN GLIOMA CELLS IN THE TUMOR PERIPHERY.

artículo científico publicado en 2015

Small cell glioblastoma or small cell carcinoma: a case report and review of the literature.

artículo científico publicado en 2013

TMIC-18TUMOR-ASSOCIATED MICROGLIA/MACROPHAGES ARE ASSOCIATED WITH POOR PROGNOSIS IN HIGH-GRADE GLIOMAS AND CONTRIBUTE TO THE GLIOBLASTOMA STEM CELL-LIKE NICHES.

artículo científico publicado en 2015

Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics

artículo científico publicado en 2020

The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.

artículo científico publicado en 2014

Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value

artículo científico publicado en 2017

Trends in tumors in the central nervous system in elderly in Denmark, 2008-2012.

artículo científico publicado en 2016

Tumor-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumor subtype.

artículo científico publicado en 2017

What is the clinical value of cancer stem cell markers in gliomas?

artículo científico publicado en 2013

Lista de obras de

A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response

A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).

APNG as a prognostic marker in patients with glioblastoma.

Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival

Clinical value of CD133 and nestin in patients with glioma: a population-based study

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.

Expression and prognostic value of JAM-A in gliomas.

Expression and prognostic value of the WEE1 kinase in gliomas.

Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype

High levels of c-Met is associated with poor prognosis in glioblastoma

MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.

Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls

P01.083 Expression and prognostic value of the immune checkpoint molecule galectin-9 in glioblastomas

P01.114 Expression and prognostic value of the immune checkpoint molecule galectin-9 in glioblastomas

P04.09THE PROGNOSTIC POTENTIAL OF CD133 AND NESTIN IN A POPULATION-BASED COHORT OF GLIOMA PATIENTS.

P04.16THE BIOMARKER POTENTIAL OF MGMT PROTEIN EXPRESSION IN GLIOBLASTOMA IS IMPROVED BY EXCLUSION OF NON-TUMOR CELLS.

P04.25 Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas

P04.41 Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas

PATH-52. TIME-VARYING EFFECT OF MGMT METHYLATION LEVEL ON SURVIVAL OF GLIOBLASTOMA MULTIFORME

Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival

Prognostic value of Musashi-1 in gliomas.

Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.

Quality of life in patients with cancer during the COVID-19 pandemic - a Danish cross-sectional study (COPICADS)

STEM-13EXPRESSION OF STEM CELL, PROLIFERATION AND CHEMORESISTANCE MARKERS IN GLIOMA CELLS IN THE TUMOR PERIPHERY.

Small cell glioblastoma or small cell carcinoma: a case report and review of the literature.

TMIC-18TUMOR-ASSOCIATED MICROGLIA/MACROPHAGES ARE ASSOCIATED WITH POOR PROGNOSIS IN HIGH-GRADE GLIOMAS AND CONTRIBUTE TO THE GLIOBLASTOMA STEM CELL-LIKE NICHES.

Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics

The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.

Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value

Trends in tumors in the central nervous system in elderly in Denmark, 2008-2012.

Tumor-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumor subtype.

What is the clinical value of cancer stem cell markers in gliomas?